Development of a Prospective and Monocentric Clinical and Biological Database in Epithelial Ovarian, Fallopian Tube, and Primitive Peritoneal Cancers

What this Trial Is About

Researchers are creating a clinical and biological database focused on epithelial ovarian cancer, fallopian tube cancer, and primitive peritoneal cancer. This database aims to gather blood and tissue samples along with clinical data to enhance scientific understanding and support the development of new cancer treatments. The study is designed to identify factors predicting treatment response, biological tumor markers linked to survival, and prognostic factors after cancer recurrence. Participants will have blood samples taken at multiple points: before treatment, after chemotherapy, after interval surgery, and upon cancer recurrence. Tissue samples from both tumor and healthy areas will be collected during surgery. Alongside these biological samples, standardized clinical information will be recorded in the database to support research. During the study, participants will provide informed consent and undergo sample collections as scheduled. Researchers will monitor the proportion of patients consenting to participate over three years. The study involves regular collection of clinical and biological data to advance understanding of these cancers and aid future research efforts. Participation includes sample collection at specific times related to treatment and surgery, with data securely stored for scientific use.

Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers